9408

    543524

    RAINBOW

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    RAINBOW CHILDRENS MED LTD Share Price Today

    RAINBOW CHILDRENS MED LTD is currently trading at ₹1470, up by ₹0.5 from the previous close. The stock touched an intraday high of ₹1489.50 and a low of ₹1464.30 during the latest trading session. Over the past one year, RAINBOW CHILDRENS MED LTD has delivered a loss of 3.71%, while the stock has gained 5.54% in the last one month.

    RAINBOW CHILDRENS MED LTD performance

    Today’s low Today’s high
    ₹ 1464.30 ₹ 1489.50
    ₹ 1469.50
    52 week low 52 week high
    ₹ 1084.00 ₹ 1593.70
    ₹ 1469.50
    Open Price ₹ 1480.00
    Prev. Close ₹ 1469.50
    Volume (Shares) 22597.00
    Total traded value ₹ 332.06
    Upper Circuit ₹ 1763.40
    Lower Circuit ₹ 1175.60
    info

    Investment Returns

    Over 1 Month 5.54% Over 3 Months 18.26% Over 6 Months 24.82% Over 1 Year -3.71%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    RAINBOW CHILDRENS MED LTD fundamentals


    • Market cap (Cr) 14,925.20
    • P/E Ratio (TTM) 60.29
    • Beta 0.51
    • Book Value / share 165.92
    • Return on equity 15.74%
    • EPS (TTM) 21.57
    • Dividend yield 0.24%
    • Net profit/quarter (Cr) 59.31
    info icon alternate text
    • Market cap (Cr) 14,919.60
    • P/E Ratio (TTM) 60.29
    • Beta 0.44
    • Book Value / share 165.92
    • Return on equity 15.74%
    • EPS (TTM) 21.57
    • Dividend yield 0.24%
    • Net profit/quarter (Cr) 59.31
    info icon alternate text

    RAINBOW CHILDRENS MED LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 408.06
    Operating Expense 333.29
    Net Profit 59.31
    Net Profit Margin (%) 14.53
    Earnings Per Share (EPS) 5.85
    EBITDA 132.63
    Effective Tax Rate (%) 24.42
    Particulars DEC 2025 (Values in Cr)
    Revenue 394.35
    Operating Expense 316.67
    Net Profit 65.82
    Net Profit Margin (%) 16.69
    Earnings Per Share (EPS) 6.48
    EBITDA 141.43
    Effective Tax Rate (%) 25.56
    Particulars SEP 2025 (Values in Cr)
    Revenue 408.50
    Operating Expense 318.27
    Net Profit 73.17
    Net Profit Margin (%) 17.91
    Earnings Per Share (EPS) 7.20
    EBITDA 148.89
    Effective Tax Rate (%) 25.64
    Particulars JUN 2025 (Values in Cr)
    Revenue 334.75
    Operating Expense 285.21
    Net Profit 51.72
    Net Profit Margin (%) 15.45
    Earnings Per Share (EPS) 5.09
    EBITDA 118.80
    Effective Tax Rate (%) 24.84
    Particulars MAR 2025 (Values in Cr)
    Revenue 354.00
    Operating Expense 293.15
    Net Profit 54.54
    Net Profit Margin (%) 15.40
    Earnings Per Share (EPS) 5.37
    EBITDA 124.72
    Effective Tax Rate (%) 27.03
    Particulars MAR 2026 (Values in Cr)
    Revenue 1545.66
    Operating Expense 1253.46
    Net Profit 250.02
    Net Profit Margin (%) 16.17
    Earnings Per Share (EPS) 24.62
    EBITDA 541.78
    Effective Tax Rate (%) 25.17
    Particulars MAR 2025 (Values in Cr)
    Revenue 1454.51
    Operating Expense 1181.37
    Net Profit 237.58
    Net Profit Margin (%) 16.33
    Earnings Per Share (EPS) 23.40
    EBITDA 523.42
    Effective Tax Rate (%) 26.23
    Particulars MAR 2024 (Values in Cr)
    Revenue 1236.56
    Operating Expense 984.30
    Net Profit 214.89
    Net Profit Margin (%) 17.37
    Earnings Per Share (EPS) 21.17
    EBITDA 450.44
    Effective Tax Rate (%) 25.70
    Particulars MAR 2023 (Values in Cr)
    Revenue 1113.99
    Operating Expense 867.76
    Net Profit 205.89
    Net Profit Margin (%) 18.48
    Earnings Per Share (EPS) 20.40
    EBITDA 408.62
    Effective Tax Rate (%) 24.53
    Particulars MAR 2022 (Values in Cr)
    Revenue 924.60
    Operating Expense 755.68
    Net Profit 142.29
    Net Profit Margin (%) 15.38
    Earnings Per Share (EPS) 15.18
    EBITDA 316.74
    Effective Tax Rate (%) 25.00
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 164.37
    ROE % 18.07
    ROCE % 18.19
    Total Debt to Total Equity 0.53
    EBITDA Margin 34.68
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 144.58
    ROE % 17.91
    ROCE % 19.04
    Total Debt to Total Equity 0.56
    EBITDA Margin 35.97
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 124.03
    ROE % 18.83
    ROCE % 19.48
    Total Debt to Total Equity 0.58
    EBITDA Margin 36.20
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 104.42
    ROE % 25.72
    ROCE % 24.07
    Total Debt to Total Equity 0.69
    EBITDA Margin 36.68
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 62.93
    ROE % 27.00
    ROCE % 22.55
    Total Debt to Total Equity 1.05
    EBITDA Margin 33.56
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 165.94
    ROE % 15.74
    ROCE % 17.28
    Total Debt to Total Equity 0.48
    EBITDA Margin 35.29
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 146.58
    ROE % 17.13
    ROCE % 18.58
    Total Debt to Total Equity 0.53
    EBITDA Margin 36.27
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 126.62
    ROE % 18.11
    ROCE % 19.04
    Total Debt to Total Equity 0.54
    EBITDA Margin 36.69
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 107.23
    ROE % 24.03
    ROCE % 23.23
    Total Debt to Total Equity 0.63
    EBITDA Margin 36.95
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 66.49
    ROE % 26.10
    ROCE % 22.51
    Total Debt to Total Equity 0.93
    EBITDA Margin 34.56
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 33.89
    Total Assets 2774.84
    Total Liabilities 2774.84
    Total Equity 1663.58
    Share Outstanding 10
    Price to Book Ratio 7.01
    Return on Assets (%) 10.03
    Return on Capital (%) 16.73
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 20.27
    Total Assets 2376.98
    Total Liabilities 2376.98
    Total Equity 1475.01
    Share Outstanding 10
    Price to Book Ratio 9.55
    Return on Assets (%) 10.24
    Return on Capital (%) 16.5
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 10.12
    Total Assets 2170.40
    Total Liabilities 2170.40
    Total Equity 1264.92
    Share Outstanding 10
    Price to Book Ratio 10.25
    Return on Assets (%) 9.99
    Return on Capital (%) 17.16
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 45.50
    Total Assets 1776.30
    Total Liabilities 1776.30
    Total Equity 1064.91
    Share Outstanding 10
    Price to Book Ratio 6.81
    Return on Assets (%) 11.86
    Return on Capital (%) 19.8
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 185.21
    Total Assets 1295.74
    Total Liabilities 1295.74
    Total Equity 606.26
    Share Outstanding 9
    Price to Book Ratio 0.00
    Return on Assets (%) 10.67
    Return on Capital (%) 21.34
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 17.28
    Total Assets 2648.38
    Total Liabilities 2648.38
    Total Equity 1689.05
    Share Outstanding 10
    Price to Book Ratio 7.01
    Return on Assets (%) 9.44
    Return on Capital (%) 14.8
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 16.91
    Total Assets 2354.22
    Total Liabilities 2354.22
    Total Equity 1488.54
    Share Outstanding 10
    Price to Book Ratio 9.55
    Return on Assets (%) 10.09
    Return on Capital (%) 15.96
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 7.49
    Total Assets 2150.43
    Total Liabilities 2150.43
    Total Equity 1285.25
    Share Outstanding 10
    Price to Book Ratio 10.25
    Return on Assets (%) 9.99
    Return on Capital (%) 16.72
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 37.14
    Total Assets 1753.41
    Total Liabilities 1753.41
    Total Equity 1088.38
    Share Outstanding 10
    Price to Book Ratio 6.81
    Return on Assets (%) 11.74
    Return on Capital (%) 18.92
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 175.14
    Total Assets 1285.36
    Total Liabilities 1285.36
    Total Equity 636.29
    Share Outstanding 9
    Price to Book Ratio 0.00
    Return on Assets (%) 11.07
    Return on Capital (%) 20.99
    Particulars MAR 2026 (Values in Cr)
    Net Income 358.22
    Cash from Operations 521.19
    Cash from Investing -258.64
    Cash from Financing -147.37
    Net change in Cash 13.63
    Free Cash Flow 737.64
    Particulars MAR 2025 (Values in Cr)
    Net Income 330.00
    Cash from Operations 481.25
    Cash from Investing -267.79
    Cash from Financing -117.72
    Net change in Cash 10.13
    Free Cash Flow 626.92
    Particulars MAR 2024 (Values in Cr)
    Net Income 294.81
    Cash from Operations 410.01
    Cash from Investing -226.46
    Cash from Financing -101.78
    Net change in Cash -6.84
    Free Cash Flow 763.59
    Particulars MAR 2023 (Values in Cr)
    Net Income 281.77
    Cash from Operations 409.64
    Cash from Investing -465.20
    Cash from Financing 143.40
    Net change in Cash 6.98
    Free Cash Flow 550.94
    Particulars MAR 2022 (Values in Cr)
    Net Income 187.34
    Cash from Operations 286.40
    Cash from Investing -175.34
    Cash from Financing -44.06
    Net change in Cash 4.32
    Free Cash Flow 348.62
    Particulars MAR 2026 (Values in Cr)
    Net Income 334.11
    Cash from Operations 476.05
    Cash from Investing -241.45
    Cash from Financing -139.06
    Net change in Cash 0.39
    Free Cash Flow 675.95
    Particulars MAR 2025 (Values in Cr)
    Net Income 322.08
    Cash from Operations 469.08
    Cash from Investing -262.69
    Cash from Financing -112.94
    Net change in Cash 9.40
    Free Cash Flow 612.39
    Particulars MAR 2024 (Values in Cr)
    Net Income 289.21
    Cash from Operations 392.49
    Cash from Investing -213.72
    Cash from Financing -96.99
    Net change in Cash -4.30
    Free Cash Flow 744.58
    Particulars MAR 2023 (Values in Cr)
    Net Income 272.83
    Cash from Operations 393.10
    Cash from Investing -460.27
    Cash from Financing 147.68
    Net change in Cash 2.19
    Free Cash Flow 532.79
    Particulars MAR 2022 (Values in Cr)
    Net Income 189.74
    Cash from Operations 276.08
    Cash from Investing -169.20
    Cash from Financing -41.13
    Net change in Cash 3.72
    Free Cash Flow 334.60
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8843.00 65.00 13.42 127148.77 6680.00 9008.90
    FORTIS MALAR HOSPITALS LIMITED 50.05 22.65 2.73 93.80 40.75 76.00
    SHREE PACETRONIX LTD. 124.80 14.89 2.62 46.80 71.00 283.15
    TRANSGENE BIOTEK LTD. 2.95 0.00 2.66 22.35 1.83 5.17
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8843.00 84.69 12.76 127148.77 6680.00 9008.90
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 37.12 0.00 -9.03 27.73 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5858.50 26.22 4.85 6409.20 5010.00 6725.00

    RAINBOW CHILDRENS MED LTD shareholding pattern

    Holding
    11.57%
    49.83%
    16.02%
    22.56%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    RAINBOW CHILDRENS MED LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1469.50 -0.94 redarrow
    red-green-graph indicator
    6 Bearish
    10 Bullish
    • 5 Days 1476.60
    • 26 Days 1453.40
    • 10 Days 1475.90
    • 50 Days 1413.30
    • 12 Days 1474.10
    • 100 Days 1362.70
    • 20 Days 1463.20
    • 200 Days 1343.80
    1478.30 PIVOT
    First Support 1469.60 First Resistance 1492.20 Second Support 1455.70 Second Resistance 1500.90 Third Support 1447.00 Third Resistance 1514.80
    RSI 59.34 ADX 19.11 MACD 20.72 Williams % R -26.55 Commodity Channel Index (CCI) 47.26
    Date 2026-07-27 Week 29137.00 Same Day 24712.00 Month 46089.00
    1 Year 0.52 3 Year 0.37
    Over 1 Month
    5.54% down
    Over 1 Year
    -3.71% down
    Over 3 Months
    18.26% down
    Over 3 Years
    11.21% down
    Over 6 Months
    24.82% down
    Over 5 Years
    26.93% down

    RAINBOW CHILDRENS MED LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    21 Jul 2026 3.5 Final 21 Jul 2026 Equity shares
    27 Jun 2025 3.0 Final 28 Jun 2025 Equity shares
    23 Jul 2024 3.0 Final 23 Jul 2024 Equity shares
    22 Jun 2023 3.0 Final 22 Jun 2023 Equity shares
    07 Sep 2022 2.0 Final 08 Sep 2022 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    21 Jul 2026 3.5 Final 21 Jul 2026 Equity shares
    27 Jun 2025 3.0 Final 28 Jun 2025 Equity shares
    23 Jul 2024 3.0 Final 23 Jul 2024 Equity shares
    22 Jun 2023 3.0 Final 22 Jun 2023 Equity shares
    07 Sep 2022 2.0 Final 08 Sep 2022 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Rainbow Childrens Medicare Ltd?

    Answer Field

    Rainbow Childrens Medicare Ltd share price is for NSE ₹ 1,470.00 & for BSE ₹ 0.00 as on Jul 28 2026 03:29 PM.

    What is the Market Cap of Rainbow Childrens Medicare Ltd Share?

    Answer Field

    The market cap of Rainbow Childrens Medicare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 28 2026 03:29 PM.

    What is the 52 Week High and Low of Rainbow Childrens Medicare Ltd?

    Answer Field

    The 52 Week High and Low of Rainbow Childrens Medicare Ltd for NSE is ₹ 1,593.70 and ₹ 1,084.00 and for BSE is ₹ 1,624.95 and ₹ 1,008.75.

    What is 1 year return for Rainbow Childrens Medicare Ltd?

    Answer Field

    The 1 year returns on the stock has been -3.71%.

    What is the P/E Ratio of Rainbow Childrens Medicare Ltd Share?

    Answer Field

    As on Jul 28 2026 03:29 PM the price-to-earnings (PE) ratio for Rainbow Childrens Medicare Ltd share is 60.29.

    What is the PB ratio of Rainbow Childrens Medicare Ltd Share?

    Answer Field

    As on Jul 28 2026 03:29 PM, the price-to-book (PB) ratio for Rainbow Childrens Medicare Ltd share is 165.92.

    How to Buy Rainbow Childrens Medicare Ltd Share?

    Answer Field

    You can trade in Rainbow Childrens Medicare Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Rainbow Childrens Medicare Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Rainbow Childrens Medicare Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Rainbow Childrens Medicare Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |